Advertisement
Advertisement

CRIS

CRIS logo

Curis Inc

0.90
USD
Sponsored
-0.01
-1.28%
Jan 30, 15:56 UTC -5
Closed
exchange

After-Market

0.89

-0.01
-0.78%

CRIS Earnings Reports

Positive Surprise Ratio

CRIS beat 21 of 35 last estimates.

60%

Next Report

Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
$3.25M
/
-$0.45
Implied change from Q3 25 (Revenue/ EPS)
+2.42%
/
-8.16%
Implied change from Q4 24 (Revenue/ EPS)
-2.75%
/
-64.00%

Curis Inc earnings per share and revenue

On Nov 06, 2025, CRIS reported earnings of -0.49 USD per share (EPS) for Q3 25, beating the estimate of -0.58 USD, resulting in a 16.89% surprise. Revenue reached 3.18 million, compared to an expected 2.92 million, with a 8.87% difference. The market reacted with a -10.27% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.45 USD, with revenue projected to reach 3.25 million USD, implying an decrease of -8.16% EPS, and increase of 2.42% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Curis Inc reported EPS of -$0.49, beating estimates by 16.89%, and revenue of $3.18M, 8.87% above expectations.
The stock price moved down -10.27%, changed from $1.46 before the earnings release to $1.31 the day after.
The next earning report is scheduled for Mar 30, 2026.
Based on 7 analysts, Curis Inc is expected to report EPS of -$0.45 and revenue of $3.25M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement